Your session is about to expire
← Back to Search
Microbiome Analysis for Rectal Cancer
Study Summary
This trial is testing whether the microbiome (bacteria in the gut) is different in people with rectal cancer who respond well to treatment versus those who don't.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My rectal cancer is not adenocarcinoma.I am 18 years old or older.My condition is either early (Stage I) or advanced (Stage IV) rectal cancer.I am following a complete pre-surgery cancer treatment plan.My cancer is linked to a genetic condition like HNPCC or FAP.I am receiving or have received 5FU-based chemoradiation.I am under 18 years old.I have had rectal cancer before.My condition is stage T3 rectal cancer.
- Group 1: Tissue collection
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacancies for participants in this experiment?
"Affirmative. Per the clinicaltrials.gov entry, this particular medical trial is still open for recruitment and was initially published on February 18th 2020 with its last modification made on September 28th 2021. Forty patients are needed from two sites to complete the study."
How many volunteers are being monitored as part of this research project?
"Indeed, the website clinicaltrials.gov confirms that this medical trial is still looking for subjects; it was first released on February 18th 2020 and its most recent update occurred on September 28th 2021. The study seeks to enrol 40 patients from 2 distinct sites."
Share this study with friends
Copy Link
Messenger